Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.
Cell Death Dis. 2023 Dec 6;14(12):799. doi: 10.1038/s41419-023-06337-3.
Cell Death Dis. 2023.
PMID: 38057328
Free PMC article.
Development of the first geldanamycin-based HSP90 degraders.
Wurnig S, Vogt M, Hogenkamp J, Dienstbier N, Borkhardt A, Bhatia S, Hansen FK.
Wurnig S, et al. Among authors: hogenkamp j.
Front Chem. 2023 Jun 28;11:1219883. doi: 10.3389/fchem.2023.1219883. eCollection 2023.
Front Chem. 2023.
PMID: 37448856
Free PMC article.
Item in Clipboard
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs.
von Bredow L, Schäfer TM, Hogenkamp J, Tretbar M, Stopper D, Kraft FB, Schliehe-Diecks J, Schöler A, Borkhardt A, Bhatia S, Held J, Hansen FK.
von Bredow L, et al. Among authors: hogenkamp j.
Pharmaceuticals (Basel). 2022 Mar 9;15(3):333. doi: 10.3390/ph15030333.
Pharmaceuticals (Basel). 2022.
PMID: 35337131
Free PMC article.
Item in Clipboard
Cite
Cite